Ultimate magazine theme for WordPress.

Cannabics looking to the future and using cannabinoids to fight cancer


Cannabics Pharmaceuticals Inc (OTCQB:CNBX) CEO and Co-Founder Eyal Barad spoke with Proactive Investors at the ThinkEquity Conference in New York. The Israeli-based company is developing a platform that leverages drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer.


Leave A Reply

Your email address will not be published.